|
|
Post by neil36 on Nov 4, 2022 5:07:13 GMT -5
Sanjay Singh Linkedin ProfileHere is the correct profile for the new EVP Technical Operations (thank you moderators for deleting the incorrect profile I posted last night!) Sanjay's specialty is overseeing manufacturing. He comes from Aurobindo Pharma in New Jersey. He used to work at Cipla. His profile and recommendations are worth a read. |
|
|
|
Post by akemp3000 on Nov 4, 2022 6:56:31 GMT -5
Some traders purchase on breaking news of insider management buy-ins. This one is large. Who would know more about the near-term future than a manufacturing executive who has to prepare in advance for an increase in production. It could be quite interesting to see how this along with the forthcoming call affects the pps today.
|
|
|
|
Post by neil36 on Nov 4, 2022 7:00:40 GMT -5
Some traders purchase on breaking news of insider management buy-ins. This one is large. It will be interesting to see how this along with the forthcoming call affects the pps today. I’m not so sure he bought anything. I sense he was recruited for this position and the restricted stock grants are just part of the package. The form 4 indicates the cost of his shares as zero. With that said, I find it more than a little interesting that he has a background with Cipla |
|
|
|
Post by akemp3000 on Nov 4, 2022 7:12:18 GMT -5
Interesting. So is the current Nasdaq pre-market trades currently showing 2,978,960. Hope this isn't a typo or human error. If not, this should be a really good day.
|
|
|
|
Post by cedafuntennis on Nov 4, 2022 8:44:15 GMT -5
Some traders purchase on breaking news of insider management buy-ins. This one is large. It will be interesting to see how this along with the forthcoming call affects the pps today. I’m not so sure he bought anything. I sense he was recruited for this position and the restricted stock grants are just part of the package. The form 4 indicates the cost of his shares as zero. With that said, I find it more than a little interesting that he has a background with Cipla Exactly. The Form 4 shows 0 purchase price. He was given the shares. |
|
|
|
Post by porkini on Nov 4, 2022 9:22:27 GMT -5
Sanjay Singh Linkedin ProfileHere is the correct profile for the new EVP Technical Operations (thank you moderators for deleting the incorrect profile I posted last night!) Sanjay's specialty is overseeing manufacturing. He comes from Aurobindo Pharma in New Jersey. He used to work at Cipla. His profile and recommendations are worth a read. Your link in this post points... to this post. You might want to check it again and post a correction. |
|
rebby
Researcher
Posts: 79
|
Post by rebby on Nov 4, 2022 9:39:55 GMT -5
Some traders purchase on breaking news of insider management buy-ins. This one is large. It will be interesting to see how this along with the forthcoming call affects the pps today. I’m not so sure he bought anything. I sense he was recruited for this position and the restricted stock grants are just part of the package. The form 4 indicates the cost of his shares as zero. With that said, I find it more than a little interesting that he has a background with Cipla Completely agree here, these shares were most likely part of the comp package to bring him onboard with a multi-year vesting period |
|
|
|
Post by neil36 on Nov 4, 2022 9:41:15 GMT -5
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Nov 4, 2022 12:26:41 GMT -5
I’m not so sure he bought anything. I sense he was recruited for this position and the restricted stock grants are just part of the package. The form 4 indicates the cost of his shares as zero. With that said, I find it more than a little interesting that he has a background with Cipla Completely agree here, these shares were most likely part of the comp package to bring him onboard with a multi-year vesting period Right. A sign-on bonus. |
|
rebby
Researcher
Posts: 79
|
Post by rebby on Nov 4, 2022 14:07:46 GMT -5
Completely agree here, these shares were most likely part of the comp package to bring him onboard with a multi-year vesting period Right. A sign-on bonus. I certainly wouldn’t call it a sign-on bonus as he probably won’t have any of these shares vested for at least a year and is most likely to be spread out over a 3-5 year period, which drives retention. |
|
|
|
Post by hellodolly on Nov 4, 2022 14:44:23 GMT -5
Sanjay Singh Linkedin ProfileHere is the correct profile for the new EVP Technical Operations (thank you moderators for deleting the incorrect profile I posted last night!) Sanjay's specialty is overseeing manufacturing. He comes from Aurobindo Pharma in New Jersey. He used to work at Cipla. His profile and recommendations are worth a read. CIPLA? That reminds me: Target Sample Size Total Sample Size="216" Sample Size from India ="216" Phase of Trial Phase 3 Date of First Enrollment (India) Modification(s) 25/02/2021Date of First Enrollment (Global) No Date Specified Estimated Duration of Trial Years="1" Months="2" Days="0" |
|
|
|
Post by sayhey24 on Nov 5, 2022 7:53:55 GMT -5
Are you speculating the Singh hire has to do with the India study and Cipla? For those of us who have forgotten since it was over 4 years ago investors.mannkindcorp.com/news-releases/news-release-details/mannkind-and-cipla-enter-exclusive-marketing-and-distributionSingh was ""Plant Head" Cipla Ltd · Mar 2008 - Mar 2011 · 3 yrs 1 mo The deal was signed May 2018. I think its more of a coincidence but we will see. The India study should be done and I would expect the results to mimic the 175 study. Maybe we hear Tuesday. Maybe this is the reason for the 9am call and not after hours. Maybe not, we will see. I will take any good news. What I am expecting from India based on the 175 results Superior reductions in A1c levels; Significantly more patients reached A1c target levels; Reduced postprandial glucose excursions; and No significant difference in the incidence of severe hypoglycemia |
|
|
|
Post by MnkdWASmyRtrmntPlan on Nov 5, 2022 9:05:06 GMT -5
I certainly wouldn’t call it a sign-on bonus as he probably won’t have any of these shares vested for at least a year and is most likely to be spread out over a 3-5 year period, which drives retention. This really doesn't matter, but I believe that sign-on bonuses are not typically given when you sign on. They are actually distributed 3, 6, 9, or 12 months or so AFTER signing on ... for the reason(s) you mentioned. |
|
|
|
Post by letitride on Nov 5, 2022 9:47:57 GMT -5
Im leaning with the proper credentials in manufacturing which were going to be doing a lot more of, as Peds and CIPLA Trials wrap up. CIPLA connection is the bonus round.
|
|
